Labels play a critical role in the pharmaceutical industry, ensuring patient safety, maintaining regulatory compliance for companies and facilitating supply chain integrity. In an industry as large as this, many issues can arise if something as crucial as labelling goes awry.
Thus, companies in the pharma sphere have every reason to adopt the latest in label technology. Smart labels have shown great promise in their ability to digitalise supply chains, optimise inventory management and improve companies' productivity.
With some of the biggest pain points in manufacturing, including traceability, compliance, anti-counterfeiting, inventory control and error reduction, smart labels are increasingly looking like a necessity for those in the pharma and biotech industries.
These labels move beyond simple identification to provide real-time data, enhanced security and improved patient outcomes.
Companies such as Schreiner MediPharm are at the forefront of developing such technologies. The company has designed a range of smart labels with both RFID (Radio Frequency Identification) and NFC (Near Field Communication) capability and describes itself as the leading expert in pharma RFID-label development and supply.
Emily Letton speaks to Sebastian Muenscher, Product Manager RFID/NFC Solutions at Schreiner MediPharm, to learn more about the company's technologies and how it is innovating in a crucial part of the pharmaceutical landscape.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.